TerminatedPhase 4

Combined Use of Oxytocin and Misoprostol in the Prevention of Post Partum Haemorrhage

Stopped: reason of halt prematurely: futility of the trial

France1,721 participantsStarted 2010-03

Plain-language summary

To demonstrate that the combined used of oxytocin and misoprostol prevent from post partum haemorrhage better than oxytocin alone, following vaginal birth at 36 to 42 weeks.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women\>18 years, * during first stage of normal labor, * at 36 to 42 weeks, * with epidural analgesia and informed signed consent Exclusion Criteria: * Cesarean section delivery, * clotting disorders, * prostaglandin allergy, * absent consent.

What they're measuring

Occurrence of post partum hemorrhage > 500mL in 1 hour

Timeframe: 1 HOUR

Trial details

NCT IDNCT01113229

SponsorAssistance Publique - Hôpitaux de Paris

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-07

View on ClinicalTrials.gov More Hemorrhage; Complicating Delivery trials